Annual Current Liabilities
$6.57 M
-$1.08 M-14.12%
December 31, 2023
Summary
- As of February 12, 2025, ERNA annual total current liabilities is $6.57 million, with the most recent change of -$1.08 million (-14.12%) on December 31, 2023.
- During the last 3 years, ERNA annual current liabilities has risen by +$3.45 million (+110.34%).
- ERNA annual current liabilities is now -14.12% below its all-time high of $7.65 million, reached on December 31, 2022.
Performance
ERNA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$9.95 M
+$352.00 K+3.67%
September 30, 2024
Summary
- As of February 12, 2025, ERNA quarterly total current liabilities is $9.95 million, with the most recent change of +$352.00 thousand (+3.67%) on September 30, 2024.
- Over the past year, ERNA quarterly current liabilities has increased by +$3.38 million (+51.41%).
- ERNA quarterly current liabilities is now at all-time high.
Performance
ERNA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ERNA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.1% | +51.4% |
| 3 y3 years | +110.3% | +84.1% |
| 5 y5 years | +110.3% | +84.1% |
ERNA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | +78.8% | at high | +170.7% |
| 5 y | 5-year | -14.1% | +110.3% | at high | +218.5% |
| alltime | all time | -14.1% | +110.3% | at high | +218.5% |
Eterna Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.95 M(+3.7%) |
| Jun 2024 | - | $9.60 M(+23.6%) |
| Mar 2024 | - | $7.77 M(+18.2%) |
| Dec 2023 | $6.57 M(-14.1%) | $6.57 M(-31.7%) |
| Sep 2023 | - | $9.63 M(+34.3%) |
| Jun 2023 | - | $7.17 M(+32.5%) |
| Mar 2023 | - | $5.41 M(-29.4%) |
| Dec 2022 | $7.65 M | $7.65 M(+2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.47 M(+4.9%) |
| Jun 2022 | - | $7.12 M(+93.2%) |
| Mar 2022 | - | $3.68 M(+0.2%) |
| Dec 2021 | $3.68 M(+17.7%) | - |
| Dec 2021 | - | $3.68 M(-19.4%) |
| Sep 2021 | - | $4.56 M(-40.7%) |
| Jun 2021 | - | $7.68 M(+96.9%) |
| Mar 2021 | - | $3.90 M(+24.9%) |
| Dec 2020 | $3.13 M | $3.13 M |
FAQ
- What is Eterna Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Eterna Therapeutics?
- What is Eterna Therapeutics annual current liabilities year-on-year change?
- What is Eterna Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Eterna Therapeutics?
- What is Eterna Therapeutics quarterly current liabilities year-on-year change?
What is Eterna Therapeutics annual total current liabilities?
The current annual current liabilities of ERNA is $6.57 M
What is the all time high annual current liabilities for Eterna Therapeutics?
Eterna Therapeutics all-time high annual total current liabilities is $7.65 M
What is Eterna Therapeutics annual current liabilities year-on-year change?
Over the past year, ERNA annual total current liabilities has changed by -$1.08 M (-14.12%)
What is Eterna Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ERNA is $9.95 M
What is the all time high quarterly current liabilities for Eterna Therapeutics?
Eterna Therapeutics all-time high quarterly total current liabilities is $9.95 M
What is Eterna Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ERNA quarterly total current liabilities has changed by +$3.38 M (+51.41%)